D. Javelaud and A. Mauviel, Mammalian transforming growth factor-??s: Smad signaling and physio-pathological roles, The International Journal of Biochemistry & Cell Biology, vol.36, issue.7, pp.1161-1165, 2004.
DOI : 10.1016/S1357-2725(03)00255-3

J. Massague, J. Seoane, and D. Wotton, Smad transcription factors, Genes & Development, vol.19, issue.23, pp.2783-2810, 2005.
DOI : 10.1101/gad.1350705

URL : http://genesdev.cshlp.org/cgi/content/short/19/23/2783

B. Bierie, C. Chung, J. Parker, D. Stover, N. Cheng et al., Abrogation of TGF-?? signaling enhances chemokine production and correlates with prognosis in human breast cancer, Journal of Clinical Investigation, vol.119, issue.6, pp.1571-1582, 2009.
DOI : 10.1172/JCI37480DS1

R. Akhurst and R. Derynck, TGF-beta signaling in cancer?a double-edged sword, Trends Cell Biol, vol.11, pp.44-51, 2001.

R. Derynck, R. Akhurst, and A. Balmain, TGF-beta signaling in tumor suppression and cancer progression, Nature Genetics, vol.29, issue.2, pp.117-129, 2001.
DOI : 10.1038/ng1001-117

K. Pardali and A. Moustakas, Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer, Biochim Biophys Acta, vol.1775, pp.21-62, 2007.

C. Colmenares and E. Stavnezer, Structure and activities of the ski oncogene, Semin Cancer Biol, vol.1, pp.383-387, 1990.

C. Colmenares and E. Stavnezer, The ski oncogene induces muscle differentiation in quail embryo cells, Cell, vol.59, issue.2, pp.293-303, 1989.
DOI : 10.1016/0092-8674(89)90291-2

X. Liu, Y. Sun, R. Weinberg, and H. Lodish, Ski/Sno and TGF-?? signaling, Cytokine & Growth Factor Reviews, vol.12, issue.1, pp.1-8, 2001.
DOI : 10.1016/S1359-6101(00)00031-9

K. Luo, Ski and SnoN: negative regulators of TGF-?? signaling, Current Opinion in Genetics & Development, vol.14, issue.1, pp.65-70, 2004.
DOI : 10.1016/j.gde.2003.11.003

I. Pot and S. Bonni, SnoN in TGF-β Signaling and Cancer Biology, Current Molecular Medicine, vol.8, issue.4, pp.319-328, 2008.
DOI : 10.2174/156652408784533797

W. Xu, K. Angelis, D. Danielpour, M. Haddad, O. Bischof et al., Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor, Proceedings of the National Academy of Sciences, vol.97, issue.11, pp.5924-5929, 2000.
DOI : 10.1073/pnas.090097797

Y. Sun, X. Liu, E. Eaton, W. Lane, H. Lodish et al., Interaction of the Ski Oncoprotein with Smad3 Regulates TGF-?? Signaling, Molecular Cell, vol.4, issue.4, pp.499-509, 1999.
DOI : 10.1016/S1097-2765(00)80201-4

K. Luo, S. Stroschein, W. Wang, D. Chen, E. Martens et al., The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling, Genes & Development, vol.13, issue.17, pp.2196-2206, 1999.
DOI : 10.1101/gad.13.17.2196

J. Reed, E. Bales, W. Xu, N. Okan, D. Bandyopadhyay et al., Cytoplasmic localization of the oncogenic protein ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor Beta signaling, Cancer Res, vol.61, pp.8074-8078, 2001.

A. Krakowski, J. Laboureau, A. Mauviel, M. Bissell, and K. Luo, Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-?? signaling by sequestration of the Smad proteins, Proceedings of the National Academy of Sciences, vol.102, issue.35, pp.12437-12442, 2005.
DOI : 10.1073/pnas.0504107102

URL : https://hal.archives-ouvertes.fr/inserm-00194408

J. He, S. Tegen, A. Krawitz, G. Martin, and K. Luo, The Transforming Activity of Ski and SnoN Is Dependent on Their Ability to Repress the Activity of Smad Proteins, Journal of Biological Chemistry, vol.278, issue.33, pp.30540-30547, 2003.
DOI : 10.1074/jbc.M304016200

K. Sarker, S. Wilson, and S. Bonni, SnoN Is a Cell Type-specific Mediator of Transforming Growth Factor-?? Responses, Journal of Biological Chemistry, vol.280, issue.13, pp.13037-13046, 2005.
DOI : 10.1074/jbc.M409367200

K. Sarker, H. Kataoka, A. Chan, S. Netherton, I. Pot et al., ING2 as a Novel Mediator of Transforming Growth Factor-??-dependent Responses in Epithelial Cells, Journal of Biological Chemistry, vol.283, issue.19, pp.13269-13279, 2008.
DOI : 10.1074/jbc.M708834200

L. Scolan, E. Zhu, Q. Wang, L. Bandyopadhyay, A. Javelaud et al., Transforming Growth Factor-?? Suppresses the Ability of Ski to Inhibit Tumor Metastasis by Inducing Its Degradation, Cancer Research, vol.68, issue.9, pp.3277-3285, 2008.
DOI : 10.1158/0008-5472.CAN-07-6793

Y. Sun, X. Liu, E. Ng-eaton, H. Lodish, and R. Weinberg, SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling, Proceedings of the National Academy of Sciences, vol.96, issue.22, pp.12442-12447, 1999.
DOI : 10.1073/pnas.96.22.12442

L. Levy, M. Howell, D. Das, S. Harkin, V. Episkopou et al., Arkadia Activates Smad3/Smad4-Dependent Transcription by Triggering Signal-Induced SnoN Degradation, Molecular and Cellular Biology, vol.27, issue.17, pp.6068-6083, 2007.
DOI : 10.1128/MCB.00664-07

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1952153

Y. Nagano, K. Mavrakis, K. Lee, T. Fujii, D. Koinuma et al., Arkadia Induces Degradation of SnoN and c-Ski to Enhance Transforming Growth Factor-beta Signaling, Journal of Biological Chemistry, vol.282, issue.28, pp.20492-20501, 2007.
DOI : 10.1074/jbc.M701294200

K. Mavrakis, R. Andrew, K. Lee, C. Petropoulou, J. Dixon et al., Arkadia Enhances Nodal/TGF-?? Signaling by Coupling Phospho-Smad2/3 Activity and Turnover, PLoS Biology, vol.296, issue.3, p.67, 2007.
DOI : 10.1371/journal.pbio.0050067.sg006

D. Koinuma, M. Shinozaki, A. Komuro, K. Goto, M. Saitoh et al., Arkadia amplifies TGF-?? superfamily signalling through degradation of Smad7, The EMBO Journal, vol.8, issue.24, pp.6458-6470, 2003.
DOI : 10.1038/23293

C. Niederlander, J. Walsh, V. Episkopou, and C. Jones, Arkadia enhances nodalrelated signalling to induce mesendoderm, Nature, vol.410, issue.6830, pp.830-834, 2001.
DOI : 10.1038/35071103

Y. Inoue and T. Imamura, Regulation of TGF-?? family signaling by E3 ubiquitin ligases, Cancer Science, vol.8, issue.Suppl 1, pp.2107-2112, 2008.
DOI : 10.1111/j.1349-7006.2008.00925.x

T. Shinagawa, T. Nomura, C. Colmenares, M. Ohira, A. Nakagawara et al., Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice, Oncogene, vol.20, issue.56, pp.8100-8108, 2001.
DOI : 10.1038/sj.onc.1204987

C. Colmenares, H. Heilstedt, L. Shaffer, S. Schwartz, M. Berk et al., Loss of the SKI proto-oncogene in individuals affected with 1p36 deletion syndrome is predicted by strain-dependent defects in Ski???/??? mice, Nature Genetics, vol.30, issue.1, pp.106-109, 2002.
DOI : 10.1038/ng770

K. Krasagakis, D. Tholke, B. Farthmann, J. Eberle, U. Mansmann et al., Elevated plasma levels of transforming growth factor (TGF)-??1 and TGF-??2 in patients with disseminated malignant melanoma, British Journal of Cancer, vol.77, issue.9, pp.1492-1494, 1998.
DOI : 10.1038/bjc.1998.245

J. Reed, N. Mcnutt, V. Prieto, and A. Albino, Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression, Am J Pathol, vol.145, pp.97-104, 1994.

D. Javelaud, V. Alexaki, and A. Mauviel, Transforming growth factor-?? in cutaneous melanoma, Pigment Cell & Melanoma Research, vol.103, issue.1-2, pp.123-132, 2008.
DOI : 10.1111/j.1755-148X.2008.00450.x

U. Rodeck, T. Nishiyama, and A. Mauviel, Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells, Cancer Res, vol.59, pp.547-550, 1999.

D. Javelaud, K. Mohammad, C. Mckenna, P. Fournier, F. Luciani et al., Stable Overexpression of Smad7 in Human Melanoma Cells Impairs Bone Metastasis, Cancer Research, vol.67, issue.5, pp.2317-2324, 2007.
DOI : 10.1158/0008-5472.CAN-06-3950

URL : https://hal.archives-ouvertes.fr/inserm-00147397

D. Javelaud, V. Delmas, M. Moller, P. Sextius, J. Andre et al., Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo, Oncogene, vol.59, issue.51, pp.7624-7629, 2005.
DOI : 10.1074/jbc.M309798200

URL : https://hal.archives-ouvertes.fr/inserm-00147458

K. Mohammad, D. Javelaud, P. Fournier, M. Niewolna, C. Mckenna et al., TGF-??-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases, Cancer Research, vol.71, issue.1, pp.175-184, 2011.
DOI : 10.1158/0008-5472.CAN-10-2651

D. Chen, Q. Lin, N. Box, D. Roop, S. Ishii et al., SKI knockdown inhibits human melanoma tumor growth in vivo, Pigment Cell & Melanoma Research, vol.27, issue.6, pp.761-772, 2009.
DOI : 10.1111/j.1755-148X.2009.00603.x

J. Reed, Q. Lin, D. Chen, I. Mian, and E. Medrano, SKI pathways inducing progression of human melanoma, Cancer and Metastasis Reviews, vol.425, issue.2, pp.265-272, 2005.
DOI : 10.1007/s10555-005-1576-x

I. Poser, T. Rothhammer, S. Dooley, R. Weiskirchen, and A. Bosserhoff, Characterization of Sno expression in malignant melanoma, International Journal of Oncology, vol.26, pp.1411-1417, 2005.
DOI : 10.3892/ijo.26.5.1411

V. Alexaki, D. Javelaud, L. Van-kempen, K. Mohammad, S. Dennler et al., GLI2-Mediated Melanoma Invasion and Metastasis, JNCI Journal of the National Cancer Institute, vol.102, issue.15, pp.1148-1159, 2010.
DOI : 10.1093/jnci/djq257

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914763

T. Guise, J. Yin, R. Thomas, M. Dallas, Y. Cui et al., Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo, Bone, vol.30, issue.5, pp.670-676, 2002.
DOI : 10.1016/S8756-3282(02)00685-3

Y. Kang, P. Siegel, W. Shu, M. Drobnjak, S. Kakonen et al., A multigenic program mediating breast cancer metastasis to bone, Cancer Cell, vol.3, issue.6, pp.537-549, 2003.
DOI : 10.1016/S1535-6108(03)00132-6

J. Yin, K. Selander, J. Chirgwin, M. Dallas, B. Grubbs et al., TGF-?? signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development, Journal of Clinical Investigation, vol.103, issue.2, pp.197-206, 1999.
DOI : 10.1172/JCI3523

V. Alexaki, D. Javelaud, and A. Mauviel, JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis, Pigment Cell & Melanoma Research, vol.331, issue.4, pp.429-438, 2008.
DOI : 10.1111/j.1755-148X.2008.00466.x

B. Boone, M. Haspeslagh, and L. Brochez, Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-?? resistance, in primary cutaneous melanoma, Journal of Dermatological Science, vol.53, issue.1, pp.26-33, 2009.
DOI : 10.1016/j.jdermsci.2008.07.010

R. Lo and O. Witte, Transforming Growth Factor-?? Activation Promotes Genetic Context-Dependent Invasion of Immortalized Melanocytes, Cancer Research, vol.68, issue.11, pp.4248-4257, 2008.
DOI : 10.1158/0008-5472.CAN-07-5671

Y. Fleming, G. Ferguson, L. Spender, J. Larsson, S. Karlsson et al., TGF-??-mediated activation of RhoA signalling is required for efficient V12HaRas and V600EBRAF transformation, Oncogene, vol.270, issue.7, pp.983-993, 2009.
DOI : 10.1038/onc.2008.449

D. Javelaud and A. Mauviel, Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-??: implications for carcinogenesis, Oncogene, vol.270, issue.37, pp.5742-5750, 2005.
DOI : 10.1016/S0378-1119(00)00162-1

URL : https://hal.archives-ouvertes.fr/inserm-00147399

S. Ijland, M. Jager, B. Heijdra, J. Westphal, and R. Peek, Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines, Melanoma Research, vol.9, issue.5, pp.445-450, 1999.
DOI : 10.1097/00008390-199910000-00003

G. Liu, F. Zhang, J. Lee, and Z. Dong, Selective induction of interleukin-8 expression in metastatic melanoma cells by transforming growth factor-??1, Cytokine, vol.31, issue.3, pp.241-249, 2005.
DOI : 10.1016/j.cyto.2005.03.008

D. Schadendorf, M. Worm, K. Jurgovsky, E. Dippel, U. Reichert et al., Effects of Various Synthetic Retinoids on Proliferation and Immunophenotype of Human Melanoma Cells In Vitro, Recent Results Cancer Res, vol.139, pp.183-193, 1995.
DOI : 10.1007/978-3-642-78771-3_13

B. Janji, C. Melchior, V. Gouon, L. Vallar, and N. Kieffer, Autocrine TGF-?-regulated expression of adhesion receptors and integrin-linked kinase in HT-144 melanoma cells correlates with their metastatic phenotype, International Journal of Cancer, vol.273, issue.2, pp.255-262, 1999.
DOI : 10.1002/(SICI)1097-0215(19991008)83:2<255::AID-IJC18>3.0.CO;2-X

K. Hoek, N. Schlegel, P. Brafford, A. Sucker, S. Ugurel et al., Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature, Pigment Cell Research, vol.11, issue.4, pp.290-302, 2006.
DOI : 10.1016/S0960-9822(01)00360-8

M. Stearns, F. Garcia, K. Fudge, J. Rhim, and M. Wang, Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice, Clin Cancer Res, vol.5, pp.711-720, 1999.

G. Rodriguez, C. Haisley, J. Hurteau, T. Moser, R. Whitaker et al., Regulation of Invasion of Epithelial Ovarian Cancer by Transforming Growth Factor-??, Gynecologic Oncology, vol.80, issue.2, pp.245-253, 2001.
DOI : 10.1006/gyno.2000.6042

M. Oft, K. Heider, and H. Beug, TGF?? signaling is necessary for carcinoma cell invasiveness and metastasis, Current Biology, vol.8, issue.23, pp.1243-1252, 1998.
DOI : 10.1016/S0960-9822(07)00533-7

URL : http://doi.org/10.1016/s0960-9822(07)00533-7

A. Shah, W. Tabayoyong, S. Kundu, S. Kim, L. Van-parijs et al., Suppression of tumor metastasis by blockade of transforming growth factor beta signaling in bone marrow cells through a retroviral-mediated gene therapy in mice, Cancer Res, vol.62, pp.7135-7138, 2002.

R. Muraoka, N. Dumont, C. Ritter, T. Dugger, D. Brantley et al., Blockade of TGF-?? inhibits mammary tumor cell viability, migration, and metastases, Journal of Clinical Investigation, vol.109, issue.12, pp.1551-1559, 2002.
DOI : 10.1172/JCI0215234

M. Uhl, S. Aulwurm, J. Wischhusen, M. Weiler, J. Ma et al., SD-208, a Novel Transforming Growth Factor ?? Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma Cells In vitro and In vivo, Cancer Research, vol.64, issue.21, pp.7954-7961, 2004.
DOI : 10.1158/0008-5472.CAN-04-1013

Y. Yang, O. Dukhanina, B. Tang, M. Mamura, J. Letterio et al., Lifetime exposure to a soluble TGF-?? antagonist protects mice against metastasis without adverse side effects, Journal of Clinical Investigation, vol.109, issue.12, pp.1607-1615, 2002.
DOI : 10.1172/JCI200215333

J. Yingling, K. Blanchard, and J. Sawyer, Development of TGF-?? signalling inhibitors for cancer therapy, Nature Reviews Drug Discovery, vol.9, issue.12, pp.1011-1022, 2004.
DOI : 10.1038/35094059

J. Singh, L. Ling, J. Sawyer, W. Lee, F. Zhang et al., Transforming the TGFbeta pathway: convergence of distinct lead generation strategies on a novel kinase pharmacophore for TbetaRI (ALK5), Curr Opin Drug Discov Devel, vol.7, pp.437-445, 2004.

R. Akhurst, Large-and small-molecule inhibitors of transforming growth factor-beta signaling, Curr Opin Investig Drugs, vol.7, pp.513-521, 2006.

J. Topczewska, L. Postovit, N. Margaryan, A. Sam, A. Hess et al., Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness, Nature Medicine, vol.155, issue.8, pp.925-932, 2006.
DOI : 10.1038/nm1448

V. Bravou, A. Antonacopoulou, H. Papadaki, K. Floratou, M. Stavropoulos et al., TGF-beta repressors SnoN and Ski are implicated in human colorectal carcinogenesis, Cell Oncol, vol.31, pp.41-51, 2009.

J. Reed, D. Chen, Q. Lin, and E. Medrano, SKI is critical for repressing the growth inhibitory function of TGF- in human melanoma, Pigment Cell & Melanoma Research, vol.278, issue.4, pp.494-495, 2008.
DOI : 10.1111/j.1755-148X.2008.00476.x

U. Rodeck, K. Melber, R. Kath, H. Menssen, M. Varello et al., Constitutive Expression of Multiple Growth Factor Genes by Melanoma Cells but Not Normal Melanocytes, Journal of Investigative Dermatology, vol.97, issue.1, pp.20-26, 1991.
DOI : 10.1111/1523-1747.ep12477822

R. Moore, D. Champeval, L. Denat, S. Tan, F. Faure et al., Involvement of cadherins 7 and 20 in mouse embryogenesis and melanocyte transformation, Oncogene, vol.23, issue.40, pp.6726-6735, 2004.
DOI : 10.1038/sj.onc.1207675

J. Macdougall, H. Kobayashi, and R. Kerbel, Responsiveness of normal, dysplastic melanocytes and melanoma cells from different lesional stages of disease progression to the growth inhibitory effects of TGFbeta, Mol Cell Diff, vol.1, pp.21-40, 1993.

S. Dennler, S. Itoh, D. Vivien, P. Ten-dijke, S. Huet et al., Direct binding of Smad3 and Smad4 to critical TGFbeta -inducible elements in the promoter of human plasminogen activator inhibitor-type 1gene, The EMBO Journal, vol.17, issue.11, pp.3091-3100, 1998.
DOI : 10.1093/emboj/17.11.3091

W. El-deiry, T. Tokino, V. Velculescu, D. Levy, R. Parsons et al., WAF1, a potential mediator of p53 tumor suppression, Cell, vol.75, issue.4, pp.817-825, 1993.
DOI : 10.1016/0092-8674(93)90500-P

D. Javelaud, J. Laboureau, E. Gabison, F. Verrecchia, and A. Mauviel, Disruption of Basal JNK Activity Differentially Affects Key Fibroblast Functions Important for Wound Healing, Journal of Biological Chemistry, vol.278, issue.27, pp.24624-24628, 2003.
DOI : 10.1074/jbc.M301942200

URL : https://hal.archives-ouvertes.fr/inserm-00147462

M. Wilkes, S. Murphy, N. Garamszegi, and E. Leof, Cell-Type-Specific Activation of PAK2 by Transforming Growth Factor ?? Independent of Smad2 and Smad3, Molecular and Cellular Biology, vol.23, issue.23, pp.8878-8889, 2003.
DOI : 10.1128/MCB.23.23.8878-8889.2003